"Lipopolysaccharide Receptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including MONOCYTES; MACROPHAGES; and some GRANULOCYTES. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein.
- Lipopolysaccharide Receptors
- Lipoglycan Receptor
- Receptor, Lipoglycan
- Receptors, Lipopolysaccharide
- CD14 Antigens
- Antigens, CD14
- LPS Receptor
- Receptor, LPS
- CD14 Monocyte Differentiation Antigen
- CD14 Antigen
Below are MeSH descriptors whose meaning is more general than "Lipopolysaccharide Receptors".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Glycoproteins [D12.776.395]
- Membrane Glycoproteins [D12.776.395.550]
- GPI-Linked Proteins [D12.776.395.550.448]
- Lipopolysaccharide Receptors [D12.776.395.550.448.100]
- Membrane Proteins [D12.776.543]
- Lipid-Linked Proteins [D12.776.543.484]
- GPI-Linked Proteins [D12.776.543.484.500]
- Lipopolysaccharide Receptors [D12.776.543.484.500.100]
- Membrane Glycoproteins [D12.776.543.550]
- GPI-Linked Proteins [D12.776.543.550.418]
- Lipopolysaccharide Receptors [D12.776.543.550.418.100]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Lipopolysaccharide Receptors [D12.776.543.750.705.045]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, Differentiation, Myelomonocytic [D23.050.301.264.900]
- Lipopolysaccharide Receptors [D23.050.301.264.900.045]
- Biomarkers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, Differentiation, Myelomonocytic [D18.104.22.1680]
- Lipopolysaccharide Receptors [D22.214.171.1240.045]
Below are MeSH descriptors whose meaning is more specific than "Lipopolysaccharide Receptors".
This graph shows the total number of publications written about "Lipopolysaccharide Receptors" by people in this website by year, and whether "Lipopolysaccharide Receptors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Lipopolysaccharide Receptors" by people in Profiles.
CD14 inhibition improves survival and attenuates thrombo-inflammation and cardiopulmonary dysfunction in a baboon model of Escherichia coli sepsis. J Thromb Haemost. 2021 02; 19(2):429-443.
Transcriptional Classification and Functional Characterization of Human Airway Macrophage and Dendritic Cell Subsets. J Immunol. 2017 02 01; 198(3):1183-1201.
Flow cytometric evaluation of intracellular cytokine synthesis in peripheral mononuclear cells of women with endometriosis. Immunol Invest. 2008; 37(1):43-61.
Role of CD14 in responses to clinical isolates of Escherichia coli: effects of K1 capsule expression. Infect Immun. 2007 Nov; 75(11):5415-24.
Differential flow cytometric detection of intracellular cytokines in peripheral and peritoneal mononuclear cells of women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008 Mar; 137(1):67-76.
The molecular chaperone Hsp90 is required for signal transduction by wild-type Hck and maintenance of its constitutively active counterpart. Cell Growth Differ. 2001 Aug; 12(8):409-17.
Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharide. J Clin Invest. 1998 Dec 01; 102(11):2019-27.
Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B. Infect Immun. 1996 Sep; 64(9):3845-52.